Back to search

Addition of Alendronate to Ongoing Hormone Replacement Therapy in the Treatment of Osteoporosis: A Randomized, Controlled Clinical Trial1

Data up to Jan 2025

Published1999
Citations185
References34

Total Citations Per Year

Abstract

References (34)

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures

1996 • 3,809 citations

Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis

1995 • 2,293 citations

Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure.

1991 • 1,013 citations

LONG-TERM PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS BY ŒSTROGEN

1976 • 946 citations

Treatment of Postmenopausal Osteoporosis with Transdermal Estrogen

1992 • 824 citations

Long-Term Estrogen Replacement Therapy Prevents Bone Loss and Fractures

1985 • 788 citations

Universal standardization for dual X-ray absorptiometry: Patient and phantom cross-calibration results

1994 • 608 citations

Postmenopausal Bone Loss Is Prevented by Treatment with Low-Dosage Estrogen with Calcium

1987 • 531 citations

Prevention of Bone Loss with Alendronate in Postmenopausal Women under 60 Years of Age

1998 • 493 citations

Journal of Bone and Mineral Research

1993 • 459 citations

The Minimum Effective Dose of Estrogen for Prevention of Postmenopausal Bone Loss

1985 • 399 citations

MECHANISMS OF ACTION OF BISPHOSPHONATES

1998 • 303 citations

Prevention of Nonvertebral Fractures by Alendronate

1997 • 285 citations

Alendronate Prevents Postmenopausal Bone Loss in Women without Osteoporosis: A Double-Blind, Randomized, Controlled Trial

1998 • 271 citations

The Comparative Effect on Bone Density, Endometrium, and Lipids of Continuous Hormones as Replacement Therapy (CHART Study)

1996 • 263 citations

Estrogen treatment of patients with established postmenopausal osteoporosis

1991 • 256 citations

Low-Dose Esterified Estrogen Therapy

1997 • 226 citations

Treatment with alendronate prevents fractures in women at highest risk: results from the Fracture Intervention Trial

1997 • 223 citations

Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosis

1996 • 214 citations

Uterine activity in patients with cervical cerclage.

1990 • 205 citations

Prevention of Bone Loss With Alendronate in Postmenopausal Women Under 60 Years of Age

1998 • 203 citations

Monitoring bone resorption in early postmenopausal women by an immunoassay for cross-linked collagen peptides in urine

1994 • 202 citations

A Four-Year Randomized Controlled Trial of Hormone Replacement and Bisphosphonate, Alone or in Combination, in Women with Postmenopausal Osteoporosis

1998 • 192 citations

Timing of postmenopausal estrogen for optimal bone mineral density. The Rancho Bernardo Study

1997 • 188 citations

Low-dose esterified estrogen therapy: effects on bone, plasma estradiol concentrations, endometrium, and lipid levels. Estratab/Osteoporosis Study Group

1997 • 186 citations

Specificity of urinary excretion of cross-linked N-telopeptides of type I collagen as a marker of bone turnover

1994 • 168 citations

Combined therapy with estrogen and etidronate has an additive effect on bone mineral density in the hip and vertebrae: Four-year randomized study

1995 • 157 citations

Effects of one-year treatment with estrogens on bone mass, intestinal calcium absorption, and 25-hydroxyvitamin D-1α-hydroxylase reserve in postmenopausal osteoporosis

1988 • 157 citations

Estrogens in the prevention of osteoporosis in postmenopausal women

1989 • 156 citations

Validation of a quantitative food frequency questionnaire for rapid assessment of dietary calcium intake

1989 • 144 citations

The Effects of Estrone (Ogen) on Spinal Bone Density of Postmenopausal Women

1991 • 65 citations

Prevention of early postmenopausal bone loss using low doses of conjugated estrogens and the non-hormonal, bone-active drug ipriflavone

1995 • 50 citations

Effects of estrogen on daylong circulating calcium, phosphorus, 1,25-dihydroxyvitamin d, and parathyroid hormone in postmenopausal women

1990 • 36 citations

Deleted Work

1955 • 0 citations

Cited By (0)

Loading...